Secular Trend and Risk Factors for Antimicrobial Resistance in Escherichia coli Isolates in Switzerland 1997–2007
- 223 Downloads
Antibacterial resistance in Escherichia coli isolates of urinary infections, mainly to fluoroquinolones, is emerging. The aim of our study was to identify the secular trend of resistant E. coli isolates and to characterize the population at risk for colonization or infections with these organisms.
Patients and Methods:
Retrospective analysis of 3,430 E.coli first isolates of urine specimens from patients admitted to the University Hospital Basel in 1997, 2000, 2003, and 2007.
Resistance to ciprofloxacin, trimethoprim/sulfamethoxazole, and amoxicillin/clavulanate has increased over the 10-year study period (from 1.8% to 15.9%, 17.4% to 21.3%, and 9.5% to 14.5%, respectively). A detailed analysis of the 2007 data revealed that independent risk factors for ciprofloxacin resistance were age (5.3% < 35 years of age to 21.9% in patients > 75 years; odds ratio [OR] 1.29 per 10 years, 95% confidence interval [CI] 1.15–1.45, p < 0.001) and male gender (OR 1.59, 95% CI 1.05–2.41, p = 0.04). In contrast, nosocomial E. coli isolates were associated with lower odds of ciprofloxacin resistance (OR 0.51, 95% CI 0.28–0.67, p < 0.001). The frequency of resistant isolate rates was not influenced by the clinical significance (i.e., colonization vs urinary tract infection, UTI) or by whether the urine was taken from a urinary catheter. Importantly, the increase in ciprofloxacin resistance paralleled the increase in ciprofloxacin consumption in Switzerland (Pearson’s correlation test R2= 0.998, p = 0.002). Of note, resistance was less frequent in isolates sent in by general practitioners. However, after adjustment for age and gender, only resistance against amoxicillin/clavulanate was found to be less frequent (OR 0.34, 95% CI 0.16–0.92, p = 0.03).
Our study reveals that resistance rates have been increasing during the last decade. Published resistance rates may lack information due to important differences regarding age, gender, and probable origin of the isolates. Empirical therapy for UTI should be guided more on individual risk profile and local resistance data than on resistance data banks.
KeywordsAntimicrob Agent Resistance Rate Urinary Catheter Secular Trend Urine Specimen
- 2.Hillier S, Bell J, Heginbothom M, Roberts Z, Dunstan F, Howard A, Mason B, Butler CC: When do general practitioners request urine specimens for microbiology analysis? The applicability of antibiotic resistance surveillance based on routinely collected data. J Antimicrob Chemother 2006; 58: 1303–1306.CrossRefPubMedGoogle Scholar
- 3.Colgan R, Johnson JR, Kuskowski M, Gupta K: A prospective study of risk factors for trimethoprim-sulfamethoxazole resistance in acute uncomplicated cystitis. Antimicrob Agents Chemother 2008; 167: 2201–2206.Google Scholar
- 17.Sannes MR, Belongia EA, Kieke B, Smith K, Kieke A, Vandermause M, Bender J, Clabots C, Winokur P, Johnson JR: Predictors of antimicrobial-resistant Escherichia coli in the feces of vegetarians and newly hospitalized adults in Minnesota and Wisconsin. J Infect Dis 2008; 197: 430–434.CrossRefPubMedGoogle Scholar
- 19.McDonald LC, Chen FJ, Lo HJ, Yin HC, Lu PL, Huang CH, Chen P, Lauderdale TL, Ho M: Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures. Antimicrob Agents Chemother 2001; 45: 3084–3091.CrossRefPubMedGoogle Scholar
- 23.Hindler JF, Evangelista AT, Jenkins SG, Johnston J, Master R, McGowan Jr. JE, Stelling J: Analysis and presentation of cumulative antimicrobial susceptibility test data; approved guideline (2nd edn). Clinical and Laboratory Standards Institute, Wayne, PA 2005.Google Scholar
- 28.Karpanoja P, Nyberg ST, Bergman M, Voipio T, Paakkari P, Huovinen P, Sarkkinen H: Connection between trimethoprimsulfamethoxazole use and resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Antimicrob Agents Chemother 2008; 52: 2480–2485.CrossRefPubMedGoogle Scholar
- 30.Talan DA, Krishnadasan A, Abrahamian FM, Stamm WE, Moran GJ: Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis. Clin Infect Dis 2008; 47: 1150–1158.CrossRefPubMedGoogle Scholar